Acadia Pharmaceuticals buy Royal Bank of Canada
Start price
14.07.23
/
50%
€29.00
Target price
14.07.24
€29.37
Performance (%)
-51.36%
Price
15:32
€14.11
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals is performing very badly with a performance of -51.36%. This prediction currently runs until 14.07.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 0.073% | 0.073% |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Royal Bank of Canada from $28.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.00
28.02.24
28.02.24
€32.29
28.02.25
28.02.25
-35.89%
15:32
15:32
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.60
03.11.23
03.11.23
€30.73
03.11.24
03.11.24
-37.59%
15:32
15:32